Beijing Konruns Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 1.37% vs 7.12% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 0.83% vs 2.78% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "214.90",
          "val2": "212.00",
          "chgp": "1.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "58.10",
          "val2": "62.80",
          "chgp": "-7.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.20",
          "val2": "1.90",
          "chgp": "15.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "-0.10",
          "chgp": "200.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "48.50",
          "val2": "48.10",
          "chgp": "0.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "270.50%",
          "val2": "256.20%",
          "chgp": "1.43%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 10.99% vs -10.44% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 687.91% vs -88.54% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "908.70",
          "val2": "818.70",
          "chgp": "10.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "215.70",
          "val2": "154.30",
          "chgp": "39.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.60",
          "val2": "6.20",
          "chgp": "22.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.30",
          "val2": "-106.00",
          "chgp": "94.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "169.40",
          "val2": "21.50",
          "chgp": "687.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "197.30%",
          "val2": "143.30%",
          "chgp": "5.40%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

214.90

212.00

1.37%

Operating Profit (PBDIT) excl Other Income

58.10

62.80

-7.48%

Interest

2.20

1.90

15.79%

Exceptional Items

0.10

-0.10

200.00%

Consolidate Net Profit

48.50

48.10

0.83%

Operating Profit Margin (Excl OI)

270.50%

256.20%

1.43%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 1.37% vs 7.12% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 0.83% vs 2.78% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

908.70

818.70

10.99%

Operating Profit (PBDIT) excl Other Income

215.70

154.30

39.79%

Interest

7.60

6.20

22.58%

Exceptional Items

-6.30

-106.00

94.06%

Consolidate Net Profit

169.40

21.50

687.91%

Operating Profit Margin (Excl OI)

197.30%

143.30%

5.40%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 10.99% vs -10.44% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 687.91% vs -88.54% in Dec 2024

All Annual Results